Asma M. Aman

PRMT5 inhibition disrupts splicing and stemness in glioblastoma

Patty Sachamitr, Jolene Caifeng Ho, Felipe E. Ciamponi et al. · Nature Communications · 2021 · 205 citations · Full text

Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma

Sina Haftchenary, H. Artee Luchman, Andriana O. Jouk et al. · ACS Medicinal Chemistry Letters · 2013 · 125 citations · Full text

High-grade Gliomas, Treating Glioblastoma, Cancer Biology +21

Genotoxic and carcinogenic products arising from reductive transformations of the azo dye, Disperse Yellow 7

Vimal K. Balakrishnan, Salma Shirin, Asma M. Aman et al. · Chemosphere · 2015 · 84 citations

Disperse Yellow 7, Photocarcinogenesis, Phototoxicity +8

Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model

Jennifer Logie, Ahil N. Ganesh, Asma M. Aman et al. · Biomaterials · 2017 · 44 citations

Nanomedicine, Drug Targeting, Engineering +8

Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co- -lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumours

Karyn Ho, Asma M. Aman, Rima Al‐awar et al. · Biomaterials · 2011 · 39 citations

Ethylene Glycol, Engineering, Anti-cancer Drug Delivery +9